J-KABU SCREENER日本語
4892 · Growth

Cyfuse Biomedical K.K.

Pharmaceutical · Stock price, valuation and financial results

View watchlist →

Share prices may be delayed. Price date: 2026-11-02. Figures are provided for research and are not investment advice.

Market data

Share price¥541
Market capitalization¥5,199,983,800
P/E ratioData unavailable
P/B ratio1.96×
Dividend yield0%

Financials

Latest fiscal year: 2025

Revenue¥230,999,000
Operating income-¥828,179,000
Net income-¥763,843,000
Return on equity-27.7%
Equity ratio64.64%

Share price history

Historical prices reflect the available market data. Use the date shown with each quote.

191 trading days
2026-11-02Open 557High 560Low 541Close 541Volume 50,300
Drag to pan · scroll to zoom

Five-year financial history

Fiscal yearRevenueOperating incomeNet incomeEquity
2025¥230,999,000-¥828,179,000-¥763,843,000¥2,757,627,000
2024¥54,446,000-¥896,133,000-¥872,238,000¥2,542,406,000
2023¥61,112,000-¥697,437,000-¥589,211,000¥3,203,469,000
2022¥374,477,000Data unavailable-¥473,962,000¥3,769,801,000
2021¥708,245,000Data unavailable¥142,905,000¥1,900,114,000

J-KABU Score

PRO ONLY

11-factor stock score

Checking membership…

PRO ONLY

AI stock analysis

Checking membership…

Industry peers

Companies in the same sector, ordered by market capitalization. Compare the underlying dates before drawing conclusions.

CompanyP/EP/BDividend yieldROE
CHUGAI PHARMACEUTICAL CO.,LTD. (4519)25.95x5.67x1.93%21.42%
Takeda Pharmaceutical Company Limited (4502)Data unavailable3.21x3.07%-4.62%
Otsuka Holdings Co.,Ltd. (4578)17.18x2.11xData unavailable11.97%
DAIICHI SANKYO COMPANY,LIMITED (4568)20.6xData unavailable3.46%5.97%
Astellas Pharma Inc. (4503)15.78x2.54x3.11%15.94%
Shionogi & Co.,Ltd. (4507)18.73x2.96x2.51%8.24%

Company names without a verified English form are shown in their registered Japanese form.